<DOC>
	<DOCNO>NCT00761150</DOCNO>
	<brief_summary>The primary purpose study test efficacy 2 tablet ( twice daily ) ABT-712 , compare placebo , administer 4-week period participant moderate severe mechanical chronic low back pain ( CLBP ) .</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy ABT-712 Subjects With Moderate Severe Chronic Low Back Pain ( CLBP )</brief_title>
	<detailed_description>The study use randomize withdrawal design open label ( OL ) period prior double-blind ( DB ) period . Participants receive benefit tolerate ABT-712 OL period randomize DB period . Study drug give total 8 week , include 3 week OL , 4 week DB , 1-week DB taper . During OL period , participant take increase dos ABT-712 take 2 tablet , twice daily . During DB period , participant ABT-712 group take 2 ABT-712 tablet , twice daily throughout 4 week , participant placebo group take 2 placebo tablet twice daily .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Hydrocodone</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Adult male female subject voluntarily sign informed consent Diagnosis CLBP 6 month duration Incapacitated bedridden subject Subjects history surgical invasive intervention</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Effect sleep interference pain</keyword>
</DOC>